Global Oncology Companion Diagnostic Supply, Demand and Key Producers, 2023-2029
Page: 107
Published Date: 01 Feb 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Oncology Companion Diagnostic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
This report studies the global Oncology Companion Diagnostic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncology Companion Diagnostic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Companion Diagnostic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncology Companion Diagnostic total market, 2018-2029, (USD Million)
Global Oncology Companion Diagnostic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oncology Companion Diagnostic total market, key domestic companies and share, (USD Million)
Global Oncology Companion Diagnostic revenue by player and market share 2018-2023, (USD Million)
Global Oncology Companion Diagnostic total market by Type, CAGR, 2018-2029, (USD Million)
Global Oncology Companion Diagnostic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oncology Companion Diagnostic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott, Myriad Genetics, Inc. and bioMérieux SA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncology Companion Diagnostic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oncology Companion Diagnostic Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Oncology Companion Diagnostic Market, Segmentation by Type
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others
Global Oncology Companion Diagnostic Market, Segmentation by Application
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Companies Profiled:
Agilent Technologies, Inc.
Illumina, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Invivoscribe, Inc.
Key Questions Answered
1. How big is the global Oncology Companion Diagnostic market?
2. What is the demand of the global Oncology Companion Diagnostic market?
3. What is the year over year growth of the global Oncology Companion Diagnostic market?
4. What is the total value of the global Oncology Companion Diagnostic market?
5. Who are the major players in the global Oncology Companion Diagnostic market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Oncology Companion Diagnostic Introduction
1.2 World Oncology Companion Diagnostic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Oncology Companion Diagnostic Total Market by Region (by Headquarter Location)
1.3.1 World Oncology Companion Diagnostic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Oncology Companion Diagnostic Market Size (2018-2029)
1.3.3 China Oncology Companion Diagnostic Market Size (2018-2029)
1.3.4 Europe Oncology Companion Diagnostic Market Size (2018-2029)
1.3.5 Japan Oncology Companion Diagnostic Market Size (2018-2029)
1.3.6 South Korea Oncology Companion Diagnostic Market Size (2018-2029)
1.3.7 ASEAN Oncology Companion Diagnostic Market Size (2018-2029)
1.3.8 India Oncology Companion Diagnostic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncology Companion Diagnostic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oncology Companion Diagnostic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Oncology Companion Diagnostic Consumption Value (2018-2029)
2.2 World Oncology Companion Diagnostic Consumption Value by Region
2.2.1 World Oncology Companion Diagnostic Consumption Value by Region (2018-2023)
2.2.2 World Oncology Companion Diagnostic Consumption Value Forecast by Region (2024-2029)
2.3 United States Oncology Companion Diagnostic Consumption Value (2018-2029)
2.4 China Oncology Companion Diagnostic Consumption Value (2018-2029)
2.5 Europe Oncology Companion Diagnostic Consumption Value (2018-2029)
2.6 Japan Oncology Companion Diagnostic Consumption Value (2018-2029)
2.7 South Korea Oncology Companion Diagnostic Consumption Value (2018-2029)
2.8 ASEAN Oncology Companion Diagnostic Consumption Value (2018-2029)
2.9 India Oncology Companion Diagnostic Consumption Value (2018-2029)
3.1 World Oncology Companion Diagnostic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oncology Companion Diagnostic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oncology Companion Diagnostic in 2022
3.2.3 Global Concentration Ratios (CR8) for Oncology Companion Diagnostic in 2022
3.3 Oncology Companion Diagnostic Company Evaluation Quadrant
3.4 Oncology Companion Diagnostic Market: Overall Company Footprint Analysis
3.4.1 Oncology Companion Diagnostic Market: Region Footprint
3.4.2 Oncology Companion Diagnostic Market: Company Product Type Footprint
3.4.3 Oncology Companion Diagnostic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: Oncology Companion Diagnostic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oncology Companion Diagnostic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Oncology Companion Diagnostic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Oncology Companion Diagnostic Consumption Value Comparison
4.2.1 United States VS China: Oncology Companion Diagnostic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oncology Companion Diagnostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Oncology Companion Diagnostic Companies and Market Share, 2018-2023
4.3.1 United States Based Oncology Companion Diagnostic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oncology Companion Diagnostic Revenue, (2018-2023)
4.4 China Based Companies Oncology Companion Diagnostic Revenue and Market Share, 2018-2023
4.4.1 China Based Oncology Companion Diagnostic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oncology Companion Diagnostic Revenue, (2018-2023)
4.5 Rest of World Based Oncology Companion Diagnostic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Oncology Companion Diagnostic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Oncology Companion Diagnostic Revenue, (2018-2023)
5.1 World Oncology Companion Diagnostic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Polymerase Chain Reaction (PCR)
5.2.2 Next-Generation Sequencing (NGS)
5.2.3 Immunohistochemistry (IHC)
5.2.4 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Oncology Companion Diagnostic Market Size by Type (2018-2023)
5.3.2 World Oncology Companion Diagnostic Market Size by Type (2024-2029)
5.3.3 World Oncology Companion Diagnostic Market Size Market Share by Type (2018-2029)
6.1 World Oncology Companion Diagnostic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pathology/Diagnostic Laboratory
6.2.3 Academic Medical Center
6.3 Market Segment by Application
6.3.1 World Oncology Companion Diagnostic Market Size by Application (2018-2023)
6.3.2 World Oncology Companion Diagnostic Market Size by Application (2024-2029)
6.3.3 World Oncology Companion Diagnostic Market Size by Application (2018-2029)
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Details
7.1.2 Agilent Technologies, Inc. Major Business
7.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Product and Services
7.1.4 Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Agilent Technologies, Inc. Recent Developments/Updates
7.1.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
7.2 Illumina, Inc.
7.2.1 Illumina, Inc. Details
7.2.2 Illumina, Inc. Major Business
7.2.3 Illumina, Inc. Oncology Companion Diagnostic Product and Services
7.2.4 Illumina, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Illumina, Inc. Recent Developments/Updates
7.2.6 Illumina, Inc. Competitive Strengths & Weaknesses
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Details
7.3.2 Qiagen N.V. Major Business
7.3.3 Qiagen N.V. Oncology Companion Diagnostic Product and Services
7.3.4 Qiagen N.V. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Qiagen N.V. Recent Developments/Updates
7.3.6 Qiagen N.V. Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific Inc.
7.4.1 Thermo Fisher Scientific Inc. Details
7.4.2 Thermo Fisher Scientific Inc. Major Business
7.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product and Services
7.4.4 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Details
7.5.2 F. Hoffmann-La Roche Ltd. Major Business
7.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product and Services
7.5.4 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7.5.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.6 ARUP Laboratories
7.6.1 ARUP Laboratories Details
7.6.2 ARUP Laboratories Major Business
7.6.3 ARUP Laboratories Oncology Companion Diagnostic Product and Services
7.6.4 ARUP Laboratories Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 ARUP Laboratories Recent Developments/Updates
7.6.6 ARUP Laboratories Competitive Strengths & Weaknesses
7.7 Abbott
7.7.1 Abbott Details
7.7.2 Abbott Major Business
7.7.3 Abbott Oncology Companion Diagnostic Product and Services
7.7.4 Abbott Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Abbott Recent Developments/Updates
7.7.6 Abbott Competitive Strengths & Weaknesses
7.8 Myriad Genetics, Inc.
7.8.1 Myriad Genetics, Inc. Details
7.8.2 Myriad Genetics, Inc. Major Business
7.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Product and Services
7.8.4 Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Myriad Genetics, Inc. Recent Developments/Updates
7.8.6 Myriad Genetics, Inc. Competitive Strengths & Weaknesses
7.9 bioMérieux SA
7.9.1 bioMérieux SA Details
7.9.2 bioMérieux SA Major Business
7.9.3 bioMérieux SA Oncology Companion Diagnostic Product and Services
7.9.4 bioMérieux SA Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 bioMérieux SA Recent Developments/Updates
7.9.6 bioMérieux SA Competitive Strengths & Weaknesses
7.10 Invivoscribe, Inc.
7.10.1 Invivoscribe, Inc. Details
7.10.2 Invivoscribe, Inc. Major Business
7.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Product and Services
7.10.4 Invivoscribe, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Invivoscribe, Inc. Recent Developments/Updates
7.10.6 Invivoscribe, Inc. Competitive Strengths & Weaknesses
8.1 Oncology Companion Diagnostic Industry Chain
8.2 Oncology Companion Diagnostic Upstream Analysis
8.3 Oncology Companion Diagnostic Midstream Analysis
8.4 Oncology Companion Diagnostic Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Oncology Companion Diagnostic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Oncology Companion Diagnostic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Oncology Companion Diagnostic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Oncology Companion Diagnostic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Oncology Companion Diagnostic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oncology Companion Diagnostic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Oncology Companion Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Oncology Companion Diagnostic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Oncology Companion Diagnostic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Oncology Companion Diagnostic Players in 2022
Table 12. World Oncology Companion Diagnostic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Oncology Companion Diagnostic Company Evaluation Quadrant
Table 14. Head Office of Key Oncology Companion Diagnostic Player
Table 15. Oncology Companion Diagnostic Market: Company Product Type Footprint
Table 16. Oncology Companion Diagnostic Market: Company Product Application Footprint
Table 17. Oncology Companion Diagnostic Mergers & Acquisitions Activity
Table 18. United States VS China Oncology Companion Diagnostic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Oncology Companion Diagnostic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Oncology Companion Diagnostic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oncology Companion Diagnostic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Oncology Companion Diagnostic Revenue Market Share (2018-2023)
Table 23. China Based Oncology Companion Diagnostic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oncology Companion Diagnostic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Oncology Companion Diagnostic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Oncology Companion Diagnostic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Oncology Companion Diagnostic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Oncology Companion Diagnostic Revenue Market Share (2018-2023)
Table 29. World Oncology Companion Diagnostic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Oncology Companion Diagnostic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Oncology Companion Diagnostic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Oncology Companion Diagnostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Oncology Companion Diagnostic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Oncology Companion Diagnostic Market Size by Application (2024-2029) & (USD Million)
Table 35. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
Table 36. Agilent Technologies, Inc. Major Business
Table 37. Agilent Technologies, Inc. Oncology Companion Diagnostic Product and Services
Table 38. Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Agilent Technologies, Inc. Recent Developments/Updates
Table 40. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 41. Illumina, Inc. Basic Information, Area Served and Competitors
Table 42. Illumina, Inc. Major Business
Table 43. Illumina, Inc. Oncology Companion Diagnostic Product and Services
Table 44. Illumina, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Illumina, Inc. Recent Developments/Updates
Table 46. Illumina, Inc. Competitive Strengths & Weaknesses
Table 47. Qiagen N.V. Basic Information, Area Served and Competitors
Table 48. Qiagen N.V. Major Business
Table 49. Qiagen N.V. Oncology Companion Diagnostic Product and Services
Table 50. Qiagen N.V. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Qiagen N.V. Recent Developments/Updates
Table 52. Qiagen N.V. Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Inc. Major Business
Table 55. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product and Services
Table 56. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 58. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 59. F. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 60. F. Hoffmann-La Roche Ltd. Major Business
Table 61. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product and Services
Table 62. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 64. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 65. ARUP Laboratories Basic Information, Area Served and Competitors
Table 66. ARUP Laboratories Major Business
Table 67. ARUP Laboratories Oncology Companion Diagnostic Product and Services
Table 68. ARUP Laboratories Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. ARUP Laboratories Recent Developments/Updates
Table 70. ARUP Laboratories Competitive Strengths & Weaknesses
Table 71. Abbott Basic Information, Area Served and Competitors
Table 72. Abbott Major Business
Table 73. Abbott Oncology Companion Diagnostic Product and Services
Table 74. Abbott Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Abbott Recent Developments/Updates
Table 76. Abbott Competitive Strengths & Weaknesses
Table 77. Myriad Genetics, Inc. Basic Information, Area Served and Competitors
Table 78. Myriad Genetics, Inc. Major Business
Table 79. Myriad Genetics, Inc. Oncology Companion Diagnostic Product and Services
Table 80. Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Myriad Genetics, Inc. Recent Developments/Updates
Table 82. Myriad Genetics, Inc. Competitive Strengths & Weaknesses
Table 83. bioMérieux SA Basic Information, Area Served and Competitors
Table 84. bioMérieux SA Major Business
Table 85. bioMérieux SA Oncology Companion Diagnostic Product and Services
Table 86. bioMérieux SA Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. bioMérieux SA Recent Developments/Updates
Table 88. Invivoscribe, Inc. Basic Information, Area Served and Competitors
Table 89. Invivoscribe, Inc. Major Business
Table 90. Invivoscribe, Inc. Oncology Companion Diagnostic Product and Services
Table 91. Invivoscribe, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Oncology Companion Diagnostic Upstream (Raw Materials)
Table 93. Oncology Companion Diagnostic Typical Customers
List of Figure
Figure 1. Oncology Companion Diagnostic Picture
Figure 2. World Oncology Companion Diagnostic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oncology Companion Diagnostic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Oncology Companion Diagnostic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Oncology Companion Diagnostic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Oncology Companion Diagnostic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Oncology Companion Diagnostic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Oncology Companion Diagnostic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Oncology Companion Diagnostic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Oncology Companion Diagnostic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Oncology Companion Diagnostic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Oncology Companion Diagnostic Revenue (2018-2029) & (USD Million)
Figure 13. Oncology Companion Diagnostic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Oncology Companion Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Oncology Companion Diagnostic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncology Companion Diagnostic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncology Companion Diagnostic Markets in 2022
Figure 27. United States VS China: Oncology Companion Diagnostic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oncology Companion Diagnostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Oncology Companion Diagnostic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Oncology Companion Diagnostic Market Size Market Share by Type in 2022
Figure 31. Polymerase Chain Reaction (PCR)
Figure 32. Next-Generation Sequencing (NGS)
Figure 33. Immunohistochemistry (IHC)
Figure 34. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Figure 35. Others
Figure 36. World Oncology Companion Diagnostic Market Size Market Share by Type (2018-2029)
Figure 37. World Oncology Companion Diagnostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Oncology Companion Diagnostic Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Pathology/Diagnostic Laboratory
Figure 41. Academic Medical Center
Figure 42. Oncology Companion Diagnostic Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Agilent Technologies, Inc. Illumina, Inc. Qiagen N.V. Thermo Fisher Scientific Inc. F. Hoffmann-La Roche Ltd. ARUP Laboratories Abbott Myriad Genetics, Inc. bioMérieux SA Invivoscribe, Inc.
Related Reports
29 Jan 2021
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
